Trial Profile
A Phase II/III, Randomized, Double-Blind, Parallel-Group Study to Assess the Safety and Immunogenicity of Intramuscular A-04-01D (H5N1 influenza vaccine) in Healthy Adult Japanese Volunteers
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Pharmacodynamics
- Sponsors Denka Seiken
- 26 Nov 2015 New trial record